Ramifications of screening for breast cancer: Definition of overdiagnosis is confusing in follow-up of Malmö trial [3]

British Medical Journal

Volumn 332, Issue 7543, 2006, Pages 727-728

  Zahl, Per Henrik ^a   Mæhlen, Jan ^b  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER SCREENING; CONFIDENCE INTERVAL; DIAGNOSTIC ERROR; FOLLOW UP; HUMAN; INCIDENCE; LETTER; MAMMOGRAPHY; PRIORITY JOURNAL; SCREENING; BREAST TUMOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FEMALE; MASS SCREENING; NOTE; RANDOMIZED CONTROLLED TRIAL; STANDARD; SWEDEN;

BREAST NEOPLASMS; DIAGNOSTIC ERRORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MASS SCREENING; RANDOMIZED CONTROLLED TRIALS; SWEDEN;

EID: 33645498004     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Zackrisson S, Andersson I.BMJ, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study BMJ 2006;332:689-92. (25 March.) doi:10.1136/bmj.38764.572569.7C (published 3 March 2006).
2. Etzioni R, Urban N, Ramsey S, McIntosh M, Schwartz S, Reid B, et al. The case for early detection. Nat Rev Cancer 2003;3:243-52.
3. Zahl PH, Strand BH, Maehlen J. Breast cancer incidence in Norway and Sweden during introduction of nation-wide screening: a prospective cohort study. BMJ 2004;328:921-4.
4. Jonsson H, Johansson R, Lenner P. Increased incidence of invasive breast cancer after the introduction of service screening with mammography in Sweden. Int J Cancer 2005;117:842-7.